Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

63 results about "Stimulant drug" patented technology

Stimulants are a class of psychoactive drug that increases activity in the brain. These drugs can temporarily elevate alertness, mood, and awareness. Some stimulant drugs are legal and widely used. Many stimulants can also be addicting.

Chewing gum products containing trigeminal stimulant and method of making the same

InactiveUS20050202118A1Prolonged flavor durationImproved sensory benefitConfectioneryChewing gumFlavorStimulant
Chewing gums and methods of making same that have improved flavor duration by stimulating a trigeminal nerve of a consumer of the chewing gum are provided. The chewing gums of the present invention includes a trigeminal stimulant. The trigeminal stimulant stimulates the trigeminal nerve of the consumer to provide longer lasting flavor duration.
Owner:WM WRIGLEY JR CO

Dietary supplement for supressing appetite, enhancing and extending satiety, improving glycemic control, and stimulant free

This invention relates to a nutritional intervention composition for enhancing satiety prior to a meal and extending satiety after a meal. The nutritional intervention composition decreases food intake producing weight loss over time. The composition consists of Niacin, Vitamin B6, Calcium, Phosphorous, Magnesium, Chromium, Chitosan, Fenugreek, Ginseng, White willow bark, Garcinia cambogia, Aloe Vera gel powder, Momordica charantia, Griffonia simplicifolia, Lagerstroemia speciosa and Vanadyl sulfate. The invention does not require stimulants or anabolic ingredients. There are three phases of activity within the composition. One, enhanced satiety through elevated serotonin. Two, improved carbohydrate metabolism, reduced blood glucose and slowed gastric emptying. Three, enhanced fiber binding of lipids and excess bile acids.
Owner:NEEDLEMAN ALVIN +1

Medicinal composition for prevention of or treatment for cerebrovascular disorder and cardiopathy

A pharmaceutical composition comprising at least one of components (a) and at least one of components (b) shown in below: (a) a compound represented by the general formula (I) (wherein R1 represents a hydrogen atom or a hydroxyl group) or an acid addition salt or hydrate thereof; and (b) an ameliorant of cerebral circulation, a vasodilator, a cerebral protecting drug, an brain metabolic stimulants, an anticoagulant, an antiplatelet drug, a thrombolytic drug, an amelirant of psychiatric symptom, a antihypertensive drug, an antianginal drug, a diuretic, a cardiotonic, an antiarrhythmic drug, an antihyperlipidemic drug, an immunosuppressant, or a pharmaceutically acceptable salt (except the components shown in (a)). It is useful as a preventive or remedy for cerebrovascular disorders and cardiac diseases.
Owner:ASAHI KASEI PHARMA

Sulfamoyl Benzamides and Methods of Their Use

Novel sulfamoyl benzamide compounds, pharmaceutical compositions containing the sulfamoyl benzamide compounds, and methods of their pharmaceutical use are disclosed. In certain embodiments, the sulfamoyl benzamide compounds are agonists and / or ligands of cannabinoid receptors and may be useful, inter alia, for treating and / or preventing pain, gastrointestinal disorders, inflammation, auto-immune diseases, ischemic conditions, immune-related disorders, hypertension, neurological disorders, and neurodegenerative diseases, for providing cardioprotection against ischemic and reperfusion effects, for inducing apoptosis in malignant cells, for inhibiting mechanical hyperalgesia associated with nerve injury, and as an appetite stimulant.
Owner:APOLOR CORP

Natural plant health care product capable of calming heart, refreshing mind, tonifying brain and improving intellectual development and preparation method thereof

The invention provides a natural plant health care product capable of calming heart, refreshing mind, tonifying brain and improving intellectual development and a preparation method thereof. The health care product at least comprises the following raw materials in parts by weight: 20-200 parts of soybean, 20-200 parts of mung bean, 20-200 parts of wheat, 10-100 parts of Chinese dates, 10-100 parts of spina date seeds, 5-60 parts of lucid ganoderma and 5-30 parts of liquorice. The preparation method thereof comprises the following steps: washing the raw materials clean, denucleating, slicing, drying, heating slightly, crashing, poaching, filtering and concentrating; extracting with ethanol to obtain an extracting solution; and preparing the extracting solution into various preparations of the natural plant health care product. The health care product has the efficacies of calming the heart, tranquilizing the mind, nourishing the heart, refreshing the mind, tonifying the brain, improving the intellectual development, stabilizing emotion, replenishing heart and brain nutrition, improving and consolidating memory and the like, thus realizing the purposes of cheering spirits, concentrating attention and overcoming the difficulties and obstacles in sleep, learning and examinations caused by psychological, spiritual and physical problems; and the health care product does not contain any hormone and stimulant, and has no toxic and side effects and dependence.
Owner:柯金表

Biodegradable biocompatible carrier for use in artificial fish bait

ActiveUS8173116B1Efficient carrierBiocideCosmetic preparationsPreservativeStimulant
The subject matter disclosed herein relates generally to a biocompatible, biodegradable, and moldable plastic carrier for a fish attractant or stimulant suitable for use as a component of an artificial fish bait. The carrier comprises one or more grades of poly(vinyl alcohol), a plasticizer, a humectant, and water. It may additionally contain one or more of the following additives: fish olfactory / gustatory stimulants, visually stimulating colorants, preservatives, scrim, and biodegradation enhancers. The present subject matter additionally relates to a method for the production of such carriers and fish bait or lures incorporating the carrier.
Owner:CARR SPECIALTY BAITS

Composition and methods for evaluating an organism's response to alcohol or stimulants

This invention pertains to the identification of genes whose expression levels are altered by chronic exposure of a cell, tissue, or organism to one or more drugs of abuse (e.g. alcohol, stimulants, opiates, etc.). In one embodiment, this invention provides a method of monitoring the response of a cell a drug of abuse. The method involves contacting the cell with the drug of abuse; providing a biological sample comprising the cell; and detecting, in the sample, the expression of one or more genes or ESTs identified herein, where a difference between the expression of one or more of said genes or ESTs in said sample and one or more of said genes or ESTs in a biological sample not contacted with said drug of abuse indicates a response of the cell to the drug of abuse
Owner:RGT UNIV OF CALIFORNIA

Oral drug dosage forms compromising a fixed-dose of an adhd non-stimulant and an adhd stimulant

The present disclosure provides oral drug dosage forms comprising: (a) an erodible non-stimulant material admixed with an ADHD non-stimulant; and (b) an erodible stimulant material admixed with an ADHD stimulant, wherein the erodible non-stimulant material admixed with the ADHD non-stimulant is embedded in a substrate material, and wherein upon exposure to gastrointestinal fluid the ADHD non-stimulant is released according to a desired non-stimulant release profile and the ADHD stimulant is released according to a desired stimulant release profile. In some embodiment, the ADHD non-stimulant is released according to a sustained release profile. In some embodiments, the ADHD stimulant is released according to an immediate release profile. The oral drug dosage forms of the present disclosure are useful for the treatment of attention deficit hyperactivity disorder (ADHD). Also provided herein are methods of designing and manufacturing the oral drug dosage forms described herein.
Owner:TRIASTEK INC

Quantum dot and immunochromatography test strip rapid detection method for beta-stimulant multiresidue

ActiveCN106093322ASpecial surface effectSpecial sizeTesting foodFluorescenceQuantitative determination
The invention discloses a quantum dot and immunochromatography test strip rapid detection method for beta-stimulant multiresidue. The detection method includes the steps that a quantum dot is coupled with beta-stimulant monoclonal antibody to obtain a quantum dot and beta-stimulant monoclonal antibody labeling complex which is namely a quantum dot fluorescence probe; after the labeling complex serving as the quantum dot fluorescence probe and a sample to be detected are mixed uniformly and incubated, and an immunochromatography test strip is used for detecting the beta-stimulant residue. Multiple beta-stimulant drugs can be screened fast, the detection method is simple, fast, accurate in result, high in sensitivity, low in prices and wide in application range and has excellent application and popularization prospects, and qualitative and quantitative determination can be carried out.
Owner:广州万联生物科技有限公司

G protein-coupled receptor protein, its DNA and ligand thereof

The polypeptides in the present invention possess the effects of promoting and inhibiting the secretion of prolactin, and are thus useful as drugs for the prevention and treatment of various diseases, in terms of prolactin secretion stimulants, which are associated with the secretion of prolactin, such as hypoovarianism, spermatic underdevelopment, menopausal symptoms, hypothyroidism, etc. The polypeptides are useful as drugs for the prevention and treatment of various diseases, in terms of prolactin secretion inhibitors, which are associated with the secretion of prolactin, such as pituitary tumor, diencephalon tumor, menstrual disorder, autoimmune diseases, prolactinoma, sterility, impotence, amenorrhea, lactorrhea, acromegaly, Chiari-Frommel syndrome, Argonz-del Castilo syndrome, Forbes-Albright syndrome, lymphoma, Sheehan's syndrome, spermatogenesis disorder, etc.
Owner:TAKEDA PHARMA CO LTD

Method applicable to serum-free culture of mesenchymal stem cells

The invention discloses a method applicable to serum-free culture of mesenchymal stem cells. The method comprises a step of adding a stimulant drug thrombin into a base culture medium to stimulate mesenchymal stem cells to secrete endogenous fibronectin. The method disclosed by the invention is a method which is simple and convenient, low in cost and high in safety, effectively solves an adherence problem of the serum-free cultured mesenchymal stem cells, and also obviously promotes the mesenchymal stem cells to propagate in a serum-free culture medium at the same time. The method is applicable to serum-free culturing and propagating of clinical research-level mesenchymal stem cells.
Owner:FUZHOU GENERAL HOSPITAL OF NANJING MILITARY COMMAND P L A

Five-conjugate testing card for detecting beta-stimulant drugs and preparation method thereof

The invention relates to a five-conjugate testing card for detecting beta-stimulant drugs and a preparation method thereof and belongs to the technical field of beta-adrenergic receptor stimulant detection. A test strip is arranged in a casing of the testing card which is composed of a polyvinyl chloride (PVC) glue board, a sample pad, a colloidal gold combination pad, a coated film and absorbent cotton. A colloidal gold film is a glass cellulose film which contains colloidal gold markers of a clenbuterol monoclonal antibody, a ractopamine monoclonal antibody, a salbutamol monoclonal antibody, a phenylethanolamine A monoclonal antibody and a terbutaline monoclonal antibody. The coated film is a nitrocellulose film, wherein five detection lines T and a quality control line C are arranged on the coated film, and the quality control line C is coated with a rabbit anti-mouse immunoglobulin G (IgG) antibody. The five-conjugate testing card can simultaneously detect out clenbuterol, ractopamine, salbutamol, phenylethanolamine A and terbutaline, and is simple, convenient and fast in method, and accurate in result.
Owner:JIANGSU WISE SCI & TECH DEV

Confectionery products containing caffeine

Confectionery compositions comprising a xanthine derivative, a cooling composition and a warming composition are provided. The cooling and warming compositions are located in distinct and discrete regions within the confectionery composition and are adapted to provide sequential release profiles. The compositions herein provide xanthine derivatives as stimulants without negative aspects of xanthine derivative flavour perception.
Owner:THE PROCTER & GAMBLE COMPANY

Colloidal gold kit for detecting beta-stimulant drug and preparation method thereof

The invention discloses a colloidal gold kit for detecting a beta-stimulant drug. The kit comprises reagent strips and colloidal-gold marker micropores, the reagent strip comprises a base plate, a chromatography membrane, a sample pad arranged at two ends of the chromatography membrane, and an absorbent pad are arranged on the base plate in order, a quality control line C and a detection line arearranged on the chromatography membrane, the line C is coated with a goat-anti-mouse IgG antibody, the detection line comprises a T1 line and a T2 line, the T1 line is a ractopamine detection line, and is coated with a ractopamine antigen, the T2 line is the salbutamol, clenbuterol, brombuterol, tulobuterol, mabuterol, terbutaline, cimbuterol, clorprenaline, and cimaterol detection line, the T2 line is coated with a beta-stimulant antigen, the line C, the T1 line, and the T2 line present three parallel bands which are vertical to a long phase of a test paper strip, the colloidal-gold marker micropores contains a colloidal gold-labeled beta-stimulant polyclonal antibody and a ractopamine monoclonal antibody, by aiming at special objects of raw milk and fresh milk, ten drugs can be detectedat one time, a detection scope is enlarged, leak detection can be prevented, sensitivity is high, and stability is good.
Owner:杭州南开日新生物技术有限公司

Simple Analysis Method of Drugs

The invention provides a method for simple, rapid and inexpensive analysis of drugs such as nicotine and other drugs which are accumulated in biological samples of addictive drugger of tobacco, stimulant drug and the like. The method comprises the steps of introducing the biological sample into an injection needle, inserting the needle into an injector of a chromatograph and injecting a carrier into the needle to conduct chromatography treatment.
Owner:SHINWA CHEM INDS +2

Process for the preparation of 2-[(diphenylmethyl) thio] acetamide

Process for the preparation of 2-[(diphenylmethyl)thioacetamide, an intermediate for the preparation of Modafinil which is a CNS stimulant and used for the treatment of narcolepsia. The process comprises reacting 2-[(diphenylmethyl)thio]acetic acid with alcohols, in presence of catalytic amount of inorganic acid or organic acid at reflux temperature of alcohol to obtain corresponding ester which is reacted with ammonia to give 2-[(diphenylmethyl)thio]acetamide. If desired 2-[(diphenylmethyl)thioacetamide thus produced is reacted with hydrogen peroxide to produce Modafinil.
Owner:ALEMBIC LTD

Health product for relieving physical fatigue and preparation method thereof

The invention provides a healthy product for relieving the physical fatigue and a preparation method thereof, and relates to an anti-fatigue healthy product and a processing process thereof. The healthy product is characterized by being prepared from the following components in parts by weight: 25-45 parts of ginseng extract, 100-200 parts of acanthopanax extract, 110-210 parts of polygonatum kingianum extract, 50-110 parts of cervus elaphus linnaeus powder, 10-30 parts of starch and 2-6 parts of magnesium stearate. The preparation method comprises the following steps: screening raw and auxiliary materials; weighing the materials; mixing the materials; filling capsules; radiating and sterilizing; and inspecting and sending into warehouse. The healthy product has the characteristics of small-dosage taking, quick response, good anti-fatigue effect, no stimulant and the like, is suitable for common people and athletes, and is a relatively ideal healthy product capable of relieving physical fatigue.
Owner:HUNAN HUALAI BIOLOGICAL TECH CO LTD

Compositions for reduction of side effects

The present invention provides drug therapy formulations. In some embodiments, the present invention provides combinations of pharmaceutical agents (e.g., stimulant and non-stimulant), pharmaceutical formulations (e.g., nanoparticulate, non-nanoparticulate, etc.), and release profiles (e.g., immediate release, delayed release, sustained release, etc.) to provide therapeutic benefit with reduced side effects.
Owner:KEMPHARM INC

Pharmaceutical intermediate pyridine[2,3-d]pyrimidine-4(3H)-ketone and preparation thereof

InactiveCN101985448ABroad spectrum biological activityImprove biological activityOrganic chemistryChemical synthesisKetone
The invention provides a new pharmaceutical intermediate pyridine[2,3-d]pyrimidine-4(3H)-ketone, which belongs to the technical field of chemical synthesis. The pyridine[2,3-d]pyrimidine-4(3H)-ketone is successfully synthesized by performing focused microwave radiation on 2-sulfydryl-5,7-diarylpyridine[2,3-d]pyrimidine-4(3H)-ketone by taking dimethyl carbonate (DMC) as a methylation agent, MgO as a catalyst, DMSO as a promoter and tetrabutyl ammonium bromide as an oxidant. Experiments demonstrate that pyridine[2,3-d]pyrimidine-4(3H)-ketone has broad-spectrum bioactivity and shows high bioactivity particularly in terms of sterilization, inflammation diminishment, gout resistance, stimulant resistance, folic acid resistance, virus resistance and the like. In the synthesis process of the invention, DMC participates in the reaction as a reactant and also serves as a solvent of the reaction without other organic solvents, thereby saving the cost and being conducive to environmental protection. The invention has relatively good application prospect.
Owner:NORTHWEST NORMAL UNIVERSITY

Application of morinda officinalis extract in preparation of skeletal muscle fatigue resisting agent

The invention relates to a traditional Chinese medicine extract and an application field thereof, and discloses application of a morinda officinalis extract in preparation of a skeletal muscle fatigueresisting agent. The skeletal muscle fatigue resisting agent comprises components of 0.1-2.5 mg / mL of the morinda officinalis extract, 6-7 mg / mL of NaCl, 0.13-0.15 mg / mL of KCl, 0.1-0.3 mg / mL of NaHCO3, 0.1-0.3 mg / mL of CaCl2, 0.01-0.02 mg / mL of NaH2PO4, 1-3 mg / mL of glucose and water. A traditional Chinese herbal medicine, namely, the morinda officinalis extract is used as the main component ofthe morinda officinalis extract, the time for skeletal muscle to reach the fatigue state can be prolonged, the fatigue resisting activity of the skeletal muscle can be effectively improved, besides, no stimulant is added, and the skeletal muscle fatigue resisting agent is a safe and efficient anti-fatigue drug.
Owner:ZHEJIANG OCEAN UNIV

Stimulant detection information management method, device and equipment based on block chain

The invention discloses a stimulant detection information management method, device and equipment based on a block chain, and belongs to the technical field of networks. The method comprises the following steps: receiving a stimulant detection information entry request, wherein the stimulant detection information entry request comprises stimulant detection information of an athlete to be recorded;generating a first block based on the stimulant detection information entry request, wherein the first block is used for storing stimulant detection information of the athlete; and adding the first block into a block chain system. The stimulant detection information is written into the block chain to be stored, and the information in the block chain cannot be changed or illegally destroyed, so that the possibility of artificially tampering or counterfeiting the stimulant detection result is reduced, and the authenticity of the stimulant detection result can be ensured.
Owner:TENCENT TECH (SHENZHEN) CO LTD

Compositions and Methods for Treating Neuropsychiatric Disorders Using an Endothelin-B Receptor Agonist

The present invention relates to compositions and methods for treating neuropsychiatric disorders in vertebrates and humans. More specifically, the present invention provides for use of IRL-1620, an endothelin-B receptor agonist, in appropriate doses to be a neuroprotective and a neuroregenerative agent. Accordingly, in one aspect the disclosure provides a method of treating a neuropsychiatric disorder comprising administering to a patient in need thereof a therapeutically effective amount of an endothelin-B receptor agonist to treat the neuropsychiatric disorder. In some embodiments, the endothelin-B receptor agonist is co-administered with an additional agent to treat the neuropsychiatric disorder. In some embodiments, the additional agent is selected from the group consisting of an antidepressant, an anti-inflammatory agent, a CNS stimulant, a neuroleptic, and an anti-proliferative agent.
Owner:MID WESTERN UNIVERSITY BIRENDRANAGAR

Detection method and kit for detecting beta-receptor stimulant drugs in animal body fluid

The invention relates to a detection method for detecting beta-receptor stimulant drugs in animal body fluid. The method comprises the steps of enabling animal body fluid to be detected to come into contact with acetonitrile, ethyl alcohol or a multiwalled carbon nanotube for the first time to obtain sample extraction liquid, enabling the sample extraction liquid to come into contact with chloroauric acid solution and cetyl trimethyl ammonium bromide solution in PBS (Phosphate Buffer Solution) for the first time to obtain a reaction mixture, incubating the reaction mixture for 4-12min at 60-100 DEG C and observing the color change of the reaction mixture. The invention also provides a detection kit for detecting beta-receptor stimulant drugs in animal body fluid. The method can conveniently and rapidly detect the beta-receptor stimulant drugs in animal body fluid.
Owner:CHINA AGRI UNIV

Natural plant health care product capable of calming heart, refreshing mind, tonifying brain and improving intellectual development and preparation method thereof

The invention provides a natural plant health care product capable of calming heart, refreshing mind, tonifying brain and improving intellectual development and a preparation method thereof. The health care product at least comprises the following raw materials in parts by weight: 20-200 parts of soybean, 20-200 parts of mung bean, 20-200 parts of wheat, 10-100 parts of Chinese dates, 10-100 parts of spina date seeds, 5-60 parts of lucid ganoderma and 5-30 parts of liquorice. The preparation method thereof comprises the following steps: washing the raw materials clean, denucleating, slicing, drying, heating slightly, crashing, poaching, filtering and concentrating; extracting with ethanol to obtain an extracting solution; and preparing the extracting solution into various preparations of the natural plant health care product. The health care product has the efficacies of calming the heart, tranquilizing the mind, nourishing the heart, refreshing the mind, tonifying the brain, improving the intellectual development, stabilizing emotion, replenishing heart and brain nutrition, improving and consolidating memory and the like, thus realizing the purposes of cheering spirits, concentrating attention and overcoming the difficulties and obstacles in sleep, learning and examinations caused by psychological, spiritual and physical problems; and the health care product does not contain any hormone and stimulant, and has no toxic and side effects and dependence.
Owner:柯金表

Attention evaluation and methods for medicating

Provided are methods for diagnosing or selecting a mammal in need of a stimulant ADHD drug, conducting a non-specific electro-dermal responses (EDAs) analysis and / or an auditory sustained attention (ASAT) analysis on the mammal and administering or adjusting the dose of a stimulant ADHD drug to be administered to the mammal.
Owner:TECHNION RES & DEV FOUND LTD

Cannabinoid derivatives and methods for their preparation

Novel compounds, pharmaceutical compositions containing these compounds, and methods for their pharmaceutical use are disclosed. In certain embodiments, the compounds are agonists and / or ligands of cannabinoid receptors and may be useful, inter alia, for treating and / or preventing pain, gastrointestinal disorders, genitourinary disorders, inflammation, glaucoma, auto-immune diseases, ischemic conditions, immune-related disorders, and neurodegenerative diseases, for providing cardioprotection against ischemic and reperfusion effects, for inducing apoptosis in malignant cells, and as an appetite stimulant.
Owner:HEANEY JOHN

Compositions and methods for treating neuropsychiatric disorders using an endothelin-B receptor agonist

The present invention relates to compositions and methods for treating neuropsychiatric disorders in vertebrates and humans. More specifically, the present invention provides for use of IRL-1620, an endothelin-B receptor agonist, in appropriate doses to be a neuroprotective and a neuroregenerative agent. Accordingly, in one aspect the disclosure provides a method of treating a neuropsychiatric disorder comprising administering to a patient in need thereof a therapeutically effective amount of an endothelin-B receptor agonist to treat the neuropsychiatric disorder. In some embodiments, the endothelin-B receptor agonist is co-administered with an additional agent to treat the neuropsychiatric disorder. In some embodiments, the additional agent is selected from the group consisting of an antidepressant, an anti-inflammatory agent, a CNS stimulant, a neuroleptic, and an anti-proliferative agent.
Owner:MID WESTERN UNIVERSITY BIRENDRANAGAR

Sustained release hydrogel-based stimulant

The present invention relates to a thermo-responsive hydrogel polymer formulated with one or more active agents selected from the group consisting of menthol and menthone, wherein said active agents are effective in invigorating the user and / or effective in relieving fatigue.
Owner:UNIVERSITY OF NEW HAMPSHIRE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products